| Section | Status | BlueTeq | Name |
| 10.01.03 | Formulary |  |
Abatacept Orencia® |
| 13.05.03 | Formulary | |
Abrocitinib Cibinqo ® |
| 10.01.03 | Formulary | |
Adalimumab Biosimilars avaliable |
| 13.05.03 | Formulary | |
Adalimumab Biosimilars avaliable |
| 11.08.02 | Formulary | |
Aflibercept Eylea® |
| 02.12 | Formulary | |
Alirocumab Praluent® |
| 13.05.01 | Formulary | |
Alitretinoin Toctino® |
| 10.01.03 | Formulary | |
Apremilast |
| 13.05.03 | Formulary | |
Apremilast Otezla® |
| 09.01.04 | Formulary | |
Avatrombopag Doptelet® |
| 10.01.03 | Formulary | |
Baricitinib Olumiant® |
| 10.01.03 | Formulary | |
Bimekizumab Bimzelx® |
| 04.07.04.02 | Formulary | |
Botulinum Toxin Type A botox® |
| 13.05.03 | Formulary | |
Brodalumab Kyntheum® |
| 11.08.02 | Formulary | |
Brolucizumab Beovu® |
| 10.01.03 | Formulary | |
Certolizumab Pegol Cimzia® |
| 13.05.03 | Formulary | |
Deucravacitinib SOTYKTU |
| 11.04.01 | Formulary | |
Dexamethasone intravitreal implant Ozurdex® |
| 13.05.02 | Formulary | |
Dimethyl Fumarate Skilarence® |
| 13.05.03 | Formulary | |
Dupilumab Dupixent® |
| 09.01.04 | Formulary | |
Eltrombopag Revolade® |
| 04.07.04.02 | Formulary | |
Eptinezumab Vyepti® |
| 04.07.04.02 | Formulary | |
Erenumab Aimovig® |
| 10.01.03 | Formulary | |
Etanercept Biosimilars avaliable |
| 13.05.03 | Formulary | |
Etanercept Biosimilars avaliable |
| 02.12 | Formulary | |
Evolocumab Repatha® |
| 11.08.02 | Formulary | |
Faricimab Vabysmo ® |
| 01.05.03 | Formulary | |
Filgotinib |
| 10.01.03 | Formulary | |
Filgotinib Jyseleca® |
| 11.04.01 | Formulary | |
Fluocinolone intravitreal implant Iluvien® |
| 09.01.04 | Formulary | |
Fostamatinib TAVLESSE ® |
| 04.07.04.02 | Formulary | |
Fremanezumab Ajovy® |
| 04.07.04.02 | Formulary | |
Galcanezumab Emgality® |
| 01.05.03 | Formulary | |
Golimumab |
| 10.01.03 | Formulary | |
Golimumab Simponi® |
| 13.05.03 | Formulary | |
Guselkumab Tremfya® |
| 01.05.03 | Formulary | |
Infliximab |
| 10.01.03 | Formulary | |
Infliximab Biosimilars avaliable |
| 13.05.03 | Formulary | |
Infliximab Biosimilars avaliable |
| 06.01.01.03 | Formulary | |
Insulin pumps |
| 09.01.03 | Formulary | |
Iptacopan |
| 03.07 | Formulary | |
Ivacaftor–Tezacaftor–Elexacaftor Kaftrio® |
| 10.01.03 | Formulary | |
Ixekizumab |
| 13.05.02 | Formulary | |
Ixekizumab Taltz® |
| 04.09.01 | Formulary | |
Levodopa-Carbidopa- Entacapone Intestinal Gel (LECIG) |
| 04.09.01 | Formulary | |
Levodopa-Carbidopa Intestinal Gel (LCIG) |
| 03.07 | Formulary | |
Lumacaftor–Ivacaftor Orkambi® |
| 03.04.02 | Formulary | |
Mepolizumab |
| 01.05.03 | Formulary | |
Mirikizumab |
| 01.05.03 | Formulary | |
Ozanimod |
| 11.08.02 | Formulary | |
Ranibizumab |
| 03.04.02 | Formulary | |
Reslizumab |
| 01.05.03 | Formulary | |
Risankizumab Skyrizi® |
| 10.01.03 | Formulary | |
Risankizumab Skyrizi® |
| 13.05.03 | Formulary | |
Risankizumab Skyrizi® |
| 09.01.03 | Formulary | |
Rituximab |
| 09.01.04 | Formulary | |
Rituximab idiopathic thrombocytopenia in adults |
| 10.01.03 | Formulary | |
Rituximab (rheumatology) Biosimilars avaliable |
| 09.01.04 | Formulary | |
Romiplostim Nplate® |
| 10.01.03 | Formulary | |
Sarilumab Kevzara® |
| 10.01.03 | Formulary | |
Secukinumab |
| 13.05.03 | Formulary | |
Secukinumab Cosentyx® |
| 04.04 | Formulary | |
Solriamfetol hydrochloride Sunosi® |
| 06.05.01 | Formulary | |
Somatrogon Ngenla® |
| 04.12 | Formulary | |
Tafamidis |
| 03.07 | Formulary | |
Tezacaftor–Ivacaftor Symkevi® |
| 13.05.03 | Formulary | |
Tildrakizumab Ilumetri® |
| 10.01.03 | Formulary | |
Tocilizumab Biosimilars avaliable |
| 01.05.03 | Formulary | |
Tofacitinib |
| 10.01.03 | Formulary | |
Tofacitinib Xeljanz® |
| 06.05.02 | Formulary | |
Tolvaptan |
| 01.05.03 | Formulary | |
Upadacitinib Rinvoq ® |
| 10.01.03 | Formulary | |
Upadacitinib Rinvoq ® |
| 13.05.03 | Formulary | |
Upadacitinib Rinvoq ® |
| 10.01.03 | Formulary | |
Ustekinumab |
| 13.05.03 | Formulary | |
Ustekinumab Stelara® |
| 09.01.03 | Formulary | |
Voxelotor |